WebJul 5, 2024 · Sarepta Therapeutics' (SRPT) DMD drug sales are rising and pipeline candidates are progressing well. However, dependence on a single product for near-term growth is a concern. WebJun 10, 2024 · Exondys 51, which is dosed by weight, can cost more than $1 million per patient per year. It garnered sales of $300 million in 2024. Sarepta reported $455.9 million in sales in 2024, for both...
Sarepta Announces FDA Accelerated Approval Of EXONDYS 51
WebEXONDYS 51 is administered via intravenous infusion. Flush the intravenous access line with 0.9% Sodium Chloride Injection, USP, prior to and after infusion. Infuse the diluted EXONDYS 51 solution over 35 to 60 minutes. Do not mix other medications with EXONDYS 51 or infuse other medications concomitantly via the same intravenous access line. WebExondys 51 (eteplirsen) is a member of the miscellaneous uncategorized agents drug class and is commonly used for Duchenne Muscular Dystrophy. The cost for Exondys 51 intravenous solution (50 mg/mL) is around $1,694 for a supply of 2 milliliters, depending on the pharmacy you visit. aliena 49
Bring Me to the Payers – The Fight for Access to Exondys51
WebAs a result of Public Act 097-0689 (pdf), referred to as the Save Medicaid Access and Resources Together (SMART) Act, the department must develop utilization controls, including prior approval, for specialty drugs, oncolytic drugs, drugs for the treatment of HIV or AIDS, immunosuppressant drugs, and biological products in order to maximize … WebNov 7, 2024 · Exondys 51 is used in children with Duchenne muscular dystrophy (DMD). This medicine is not a cure for DMD, but Exondys 51 may lessen muscle weakness and muscle wasting caused by this disease. Exondys 51 was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis. WebExondys is a medicine that contains the active substance eteplirsen. It was to be available as a concentrate for solution for infusion (drip) into a vein. What was Exondys expected to be used for? Exondys was expected to be used for treating Duchenne muscular dystrophy (DMD) in patients aged from 4 years with mutation (change) in the DMD gene ... alienabili significato